Notes
The study was funded by Mundipharma International Ltd.
Reference
Dunlop W, et al. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma. Advances in Therapy : 6 Nov 2013. Available from: URL: http://dx.doi.org/10.1007/s12325-013-0062-z
Rights and permissions
About this article
Cite this article
FP/FORM cost-saving alternative for asthma. PharmacoEcon Outcomes News 692, 13 (2013). https://doi.org/10.1007/s40274-013-0909-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0909-1